MFDS
- Status: likely_approved
🇰🇷 Discase in South Korea
Discase (CHYMOPAPAIN) regulatory status in South Korea.
Marketing authorisation
Discase in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in South Korea
Frequently asked questions
Is Discase approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Discase in South Korea?
Chart Medcl is the originator. The local marketing authorisation holder may differ — check the official source linked above.